1. Home
  2. APLM vs GSUN Comparison

APLM vs GSUN Comparison

Compare APLM & GSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • GSUN
  • Stock Information
  • Founded
  • APLM 2016
  • GSUN 1997
  • Country
  • APLM United States
  • GSUN China
  • Employees
  • APLM N/A
  • GSUN N/A
  • Industry
  • APLM Blank Checks
  • GSUN Other Consumer Services
  • Sector
  • APLM Finance
  • GSUN Real Estate
  • Exchange
  • APLM Nasdaq
  • GSUN Nasdaq
  • Market Cap
  • APLM 6.9M
  • GSUN 6.4M
  • IPO Year
  • APLM N/A
  • GSUN 2022
  • Fundamental
  • Price
  • APLM $6.06
  • GSUN $2.80
  • Analyst Decision
  • APLM
  • GSUN
  • Analyst Count
  • APLM 0
  • GSUN 0
  • Target Price
  • APLM N/A
  • GSUN N/A
  • AVG Volume (30 Days)
  • APLM 28.0K
  • GSUN 74.0K
  • Earning Date
  • APLM 08-13-2025
  • GSUN 08-01-2025
  • Dividend Yield
  • APLM N/A
  • GSUN N/A
  • EPS Growth
  • APLM N/A
  • GSUN N/A
  • EPS
  • APLM N/A
  • GSUN N/A
  • Revenue
  • APLM $198,000.00
  • GSUN $10,159,020.00
  • Revenue This Year
  • APLM $415.15
  • GSUN N/A
  • Revenue Next Year
  • APLM N/A
  • GSUN N/A
  • P/E Ratio
  • APLM N/A
  • GSUN N/A
  • Revenue Growth
  • APLM N/A
  • GSUN 65.04
  • 52 Week Low
  • APLM $4.47
  • GSUN $2.19
  • 52 Week High
  • APLM $35.98
  • GSUN $8.94
  • Technical
  • Relative Strength Index (RSI)
  • APLM 48.70
  • GSUN 44.29
  • Support Level
  • APLM $5.11
  • GSUN $2.56
  • Resistance Level
  • APLM $6.56
  • GSUN $3.46
  • Average True Range (ATR)
  • APLM 0.49
  • GSUN 0.22
  • MACD
  • APLM 0.00
  • GSUN 0.03
  • Stochastic Oscillator
  • APLM 63.42
  • GSUN 37.01

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About GSUN Golden Sun Education Group Limited

Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.

Share on Social Networks: